在非洲儿童中与非伤寒型沙门氏菌病相关的遗传变异
James J Gilchrist1, Tara C Mills1, Vivek Naranbhai1
1Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Lancet (London, England)
|August 28, 2015
概括
一种STAT4基因变异增加了非洲儿童对侵袭性非伤寒沙门氏菌 (NTS) 疾病的易感性. 这一发现为宿主遗传学和NTS感染提供了新的见解,有可能指导未来的控制策略.
科学领域:
- 遗传学
- 免疫学
- 传染性疾病
背景情况:
- 非伤寒型沙门氏菌 (NTS) 在非洲儿童中引起严重的,往往致命的侵袭性疾病.
- 目前的NTS预防,诊断和治疗策略不足.
- 主体遗传在NTS易感性中起作用,但在非洲人群中尚未研究.
研究的目的:
- 研究非洲儿童对侵入性NTS疾病的宿主遗传易感性.
- 确定与NTS风险相关的特定遗传变异.
- 探索已识别的变体对免疫反应的功能影响.
主要方法:
- 在肯尼亚儿童中进行全基因组关联研究 (GWAS),在马拉维儿童中进行复制.
- 在单细胞中分析表达量的特征位点 (eQTL),以评估变异性功能.
- 马拉维NTS病例中的血清干扰素 (IFNγ) 水平与基因型的相关性.
主要成果:
- 在肯尼亚和马拉维的儿童中,STAT4内基变异与NTS敏感性有显著的关联 (组合p=1. 4×10−9).
- 这种STAT4变体作为eQTL,NTS风险等位基因与IFNγ刺激单细胞中的STAT4表达率较低有关.
- 在马拉维儿童中,NTS风险基因与急性疾病期间的血清IFNγ度降低有关.
结论:
- STAT4是入侵性NTS疾病的高度可信的遗传易感基因.
- 鉴定到的STAT4变异影响IL12-IFNγ免疫轴,影响对NTS的敏感性.
- 这项研究提供了非洲儿童NTS疾病宿主遗传决定因素的第一个证据.
更多相关视频
12:18An Allelotyping PCR for Identifying Salmonella enterica serovars Enteritidis, Hadar, Heidelberg, and Typhimurium
Published on: July 22, 2011
22.4K
11:10High-throughput Assay to Phenotype Salmonella enterica Typhimurium Association, Invasion, and Replication in Macrophages
Published on: August 11, 2014
13.3K
相关概念视频
Bacterial Gastroenteritis
46
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
46
Principles of Pharmacogenetics: Types of Genetic Variants
98
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
98
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
112
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112
